MEDULLARY (SOLID) CARCINOMA OF THE THYROID—A CLINICOPATHOLOGIC ENTITY*
Clicks: 4
ID: 306001
1959
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.9
/100
4 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #361 of 373 articles by views in the journal of clinical endocrinology & metabolism
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 373 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Medullary carcinoma is characterized by a solid nonfollicular histologic pattern, the presence of amyloid in the stroma, and a high incidence of lymph node metastases. The tumor is clinically of an intermediate rather than a high grade of malignancy, despite its undifferentiated character. It is important to distinguish it from the highly malignant solid form of anaplastic carcinoma, and from papillary carcinoma, which is of a lower grade of malignancy. Twenty-one cases are reported. Fourteen patients were women and 7 were men; the ages ranged from 33 to 66 years with a median of 50 years. The regional cervical lymph nodes contained metastases at the time of initial surgery in 10 of 21 cases (48 per cent). Distant metastases occurred in 8 patients and were principally evident in the lungs, liver and bone. Amyloid, though of variable amount, was present in the stroma of all tumors of this series. The course of the disease was usually chronic; 12 patients survived six to twenty-seven years after the initial thyroid operation. Eleven patients died (6 because of neoplasm) four months to twenty-seven years after definitive surgical treatment.
| Reference Key |
openalex_W2158510116
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | J Hazard, William A. Hawk, George Crile |
| Journal | the journal of clinical endocrinology & metabolism |
| Year | 1959 |
| DOI |
10.1210/jcem-19-1-152
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.